Page last updated: 2024-10-23

berberine and Fibrosis

berberine has been researched along with Fibrosis in 28 studies

Fibrosis: Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.

Research Excerpts

ExcerptRelevanceReference
"Berberine acts via multiple pathways to alleviate fibrosis in various tissues and shows renoprotective effects."8.31Berberine ameliorates renal interstitial inflammation and fibrosis in mice with unilateral ureteral obstruction. ( Gao, Z; Han, B; Hou, Y; Shi, H; Tan, E; Wang, L; Wang, Q; Zhu, G, 2023)
"To evaluate the effect of berberine (BBR) in preventing the development of epidural fibrosis (EF) after lumbar surgery in rats."8.12Evaluation of the effects of berberine in the prevention of epidural fibrosis in rats: An experimental research. ( Işık, E; Kaya, M; Keskin, E; Tönge, Ç, 2022)
"The nephroprotective effects of berberine were mediated in part by downregulating P2X7R and modulating DUSP6-mediated inactivation of ERK1/2 as well as by suppressing SIRT2/MDM2-triggered renal fibrosis."8.12Insights into the role of P2X7R/DUSP6/ERK1/2 and SIRT2/MDM2 signaling in the nephroprotective effect of berberine against cisplatin-induced renal fibrosis in rats. ( Ahmedy, OA; Al-Mokaddem, AK; El-Said, YAM; El-Tanbouly, DM, 2022)
"This study was designed to investigate the molecular mechanisms underlying the anti-inflammatory and anti-fibrosis effects of Berberine hydrochloride (BBR) following canalicular laceration (CL) surgical repair."7.96Berberine hydrochloride inhibits inflammation and fibrosis after canalicular laceration repair in rabbits. ( Bai, F; Huang, Y; Liu, C; Tao, H; Wang, F; Wang, L; Wang, P; Zhou, X, 2020)
"Objective To explore the effect of berberine on cardiac fibrosis of diabetic rats by observing the expressions of serum transforming growth factor-β1 (TGF-β1), connective tissue growth factor (CTGF) , collagen type 1 (Col1) and collagen type 3 (Col3) in myocardial tissues of diabetic rats after berberine treatment."7.83[Berberine inhibits cardiac fibrosis of diabetic rats]. ( He, J; Liu, G; Lu, K; Shen, Y; Song, W, 2016)
"To investigate the potential effects of berberine on renal interstitial fibrosis (RIF) of obstructed kidneys in a unilateral ureteral obstruction (UUO) rat model."7.80Berberine ameliorates renal interstitial fibrosis induced by unilateral ureteral obstruction in rats. ( He, YQ; Ma, LL; Tian, XJ; Wang, FM; Yang, YJ, 2014)
"Berberine (BR) acts as an AMP-activated protein kinase (AMPK) activator which possesses antioxidant and anti-inflammatory properties."5.56Berberine attenuates severity of chronic pancreatitis and fibrosis via AMPK-mediated inhibition of TGF-β1/Smad signaling and M2 polarization. ( Bansod, S; Doijad, N; Godugu, C, 2020)
"Cardiac fibrosis is a crucial aspect of cardiac remodeling that can severely affect cardiac function."5.51Protective role of berberine in isoprenaline-induced cardiac fibrosis in rats. ( Che, Y; Jin, YG; Shen, DF; Wang, SS; Wang, ZP; Wu, QQ; Yuan, Y, 2019)
"Berberine (BBR) has been shown to relieve several metabolic disorders, including obesity and type 2 diabetes."5.48Berberine alleviates adipose tissue fibrosis by inducing AMP-activated kinase signaling in high-fat diet-induced obese mice. ( Hua, Y; Song, Y; Wang, L; Ye, X, 2018)
"Berberine (BBR) is a material extracted from Chinese herbs, which has been used in the treatment of diabetes in Chinese medicine for thousands of years."5.46Protective effect of berberine on renal fibrosis caused by diabetic nephropathy. ( Li, Z; Zhang, W, 2017)
"Cardiac hypertrophy is a maladaptive change in response to pressure overload, and is also an important risk for developing heart failure."5.40Berberine improves pressure overload-induced cardiac hypertrophy and dysfunction through enhanced autophagy. ( Chen, SL; Iqbal, J; Li, B; Li, MH; Mao, WX; Mi, QY; Wang, ZM; Xie, HG; Yang, SH; Yu, YH; Zhang, YJ, 2014)
"Berberine acts via multiple pathways to alleviate fibrosis in various tissues and shows renoprotective effects."4.31Berberine ameliorates renal interstitial inflammation and fibrosis in mice with unilateral ureteral obstruction. ( Gao, Z; Han, B; Hou, Y; Shi, H; Tan, E; Wang, L; Wang, Q; Zhu, G, 2023)
"To evaluate the effect of berberine (BBR) in preventing the development of epidural fibrosis (EF) after lumbar surgery in rats."4.12Evaluation of the effects of berberine in the prevention of epidural fibrosis in rats: An experimental research. ( Işık, E; Kaya, M; Keskin, E; Tönge, Ç, 2022)
"Berberine (BBR), an alkaloid produced by a traditional Chinese plant, was recently attributed multiple effects on lipometabolism, inflammation, and fibrosis."4.12Potential Therapeutic Activity of Berberine in Thyroid-Associated Ophthalmopathy: Inhibitory Effects on Tissue Remodeling in Orbital Fibroblasts. ( Chen, X; Diao, J; Ma, X; Mou, P; Wei, R, 2022)
"The nephroprotective effects of berberine were mediated in part by downregulating P2X7R and modulating DUSP6-mediated inactivation of ERK1/2 as well as by suppressing SIRT2/MDM2-triggered renal fibrosis."4.12Insights into the role of P2X7R/DUSP6/ERK1/2 and SIRT2/MDM2 signaling in the nephroprotective effect of berberine against cisplatin-induced renal fibrosis in rats. ( Ahmedy, OA; Al-Mokaddem, AK; El-Said, YAM; El-Tanbouly, DM, 2022)
"Compared with the sham group, rats of the TAC group showed significantly increased cardiac hypertrophy and fibrosis, which could be ameliorated by treatment with berberine."3.96Berberine Attenuates Cardiac Hypertrophy Through Inhibition of mTOR Signaling Pathway. ( Chen, J; Chen, X; Cheng, C; Huang, S; Jiang, X; Liu, S; Xu, M, 2020)
"This study was designed to investigate the molecular mechanisms underlying the anti-inflammatory and anti-fibrosis effects of Berberine hydrochloride (BBR) following canalicular laceration (CL) surgical repair."3.96Berberine hydrochloride inhibits inflammation and fibrosis after canalicular laceration repair in rabbits. ( Bai, F; Huang, Y; Liu, C; Tao, H; Wang, F; Wang, L; Wang, P; Zhou, X, 2020)
"Objective To explore the effect of berberine on cardiac fibrosis of diabetic rats by observing the expressions of serum transforming growth factor-β1 (TGF-β1), connective tissue growth factor (CTGF) , collagen type 1 (Col1) and collagen type 3 (Col3) in myocardial tissues of diabetic rats after berberine treatment."3.83[Berberine inhibits cardiac fibrosis of diabetic rats]. ( He, J; Liu, G; Lu, K; Shen, Y; Song, W, 2016)
"The effects of berberine, dihydroberberine, canadine, stylopine, and coptisine were investigated on an in vitro model of fibrosis purposely set up."3.81In vitro studies of antifibrotic and cytoprotective effects elicited by proto-berberine alkaloids in human dermal fibroblasts. ( Bianucci, AM; Borghini, A; Pietra, D, 2015)
"To investigate the potential effects of berberine on renal interstitial fibrosis (RIF) of obstructed kidneys in a unilateral ureteral obstruction (UUO) rat model."3.80Berberine ameliorates renal interstitial fibrosis induced by unilateral ureteral obstruction in rats. ( He, YQ; Ma, LL; Tian, XJ; Wang, FM; Yang, YJ, 2014)
"Fibrosis is a general term encompassing a plethora of pathologies that span all systems and is marked by increased deposition of collagen."2.53AMPK in cardiac fibrosis and repair: Actions beyond metabolic regulation. ( Beauloye, C; Bertrand, L; Daskalopoulos, EP; Dufeys, C; Horman, S, 2016)
" Thus increasing the oral bioavailability of Pgp substrate-like drugs (PSLDs) remains a great challenge."1.62Brij-functionalized chitosan nanocarrier system enhances the intestinal permeability of P-glycoprotein substrate-like drugs. ( Chen, QL; Chu, JMT; Hu, YJ; Li, J; Linghu, KG; Wang, YT; Wong, GTC; Xiong, SH; Xiong, W; Yu, H; Zhao, GD, 2021)
"Berberine (BR) acts as an AMP-activated protein kinase (AMPK) activator which possesses antioxidant and anti-inflammatory properties."1.56Berberine attenuates severity of chronic pancreatitis and fibrosis via AMPK-mediated inhibition of TGF-β1/Smad signaling and M2 polarization. ( Bansod, S; Doijad, N; Godugu, C, 2020)
"Cardiac fibrosis is a crucial aspect of cardiac remodeling that can severely affect cardiac function."1.51Protective role of berberine in isoprenaline-induced cardiac fibrosis in rats. ( Che, Y; Jin, YG; Shen, DF; Wang, SS; Wang, ZP; Wu, QQ; Yuan, Y, 2019)
"Berberine (BBR) has been shown to relieve several metabolic disorders, including obesity and type 2 diabetes."1.48Berberine alleviates adipose tissue fibrosis by inducing AMP-activated kinase signaling in high-fat diet-induced obese mice. ( Hua, Y; Song, Y; Wang, L; Ye, X, 2018)
"Berberine (BBR) is a material extracted from Chinese herbs, which has been used in the treatment of diabetes in Chinese medicine for thousands of years."1.46Protective effect of berberine on renal fibrosis caused by diabetic nephropathy. ( Li, Z; Zhang, W, 2017)
"Berberine has proven protective effects on diabetic nephropathy, but the mechanism for its effects has not been comprehensively established."1.42Renoprotective effects of berberine through regulation of the MMPs/TIMPs system in streptozocin-induced diabetic nephropathy in rats. ( Ding, HH; Ni, WJ; Qiu, YY; Tang, LQ; Zhou, H, 2015)
"Berberine treatment of palmitate-incubated H9c2 cells reduced hypertrophy, increased α-MHC expression and decreased β-MHC expression."1.42Berberine treatment prevents cardiac dysfunction and remodeling through activation of 5'-adenosine monophosphate-activated protein kinase in type 2 diabetic rats and in palmitate-induced hypertrophic H9c2 cells. ( Chang, W; Chen, L; Hatch, GM; Meng, Z; Yao, F; Yu, Y; Zhang, M, 2015)
"Cardiac hypertrophy is a maladaptive change in response to pressure overload, and is also an important risk for developing heart failure."1.40Berberine improves pressure overload-induced cardiac hypertrophy and dysfunction through enhanced autophagy. ( Chen, SL; Iqbal, J; Li, B; Li, MH; Mao, WX; Mi, QY; Wang, ZM; Xie, HG; Yang, SH; Yu, YH; Zhang, YJ, 2014)
"Rats with renal artery stenosis were randomly assigned to two groups (n = 6 each) - ARD, or ARD+BBR - according to diet alone or in combination with BBR."1.39Berberine ameliorates chronic kidney injury caused by atherosclerotic renovascular disease through the suppression of NFκB signaling pathway in rats. ( Cao, CC; Chen, W; Chen, X; Huang, WJ; Liu, L; Miao, GG; Wan, X; Xie, HG; Zhang, Q; Zhao, Y, 2013)
"One of the main pathological changes in diabetic nephropathy is the renal fibrosis, which includes glomerulosclerosis and tubulointerstitial fibrosis."1.36Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury. ( Huang, H; Jiang, Q; Lan, T; Li, W; Liu, P; Liu, W; Shen, X; Xie, X; Zhang, X, 2010)

Research

Studies (28)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's15 (53.57)24.3611
2020's13 (46.43)2.80

Authors

AuthorsStudies
Keskin, E1
Tönge, Ç1
Kaya, M1
Işık, E1
Ma, Z1
Zhu, L1
Wang, S1
Guo, X1
Sun, B1
Wang, Q2
Chen, L2
Diao, J1
Chen, X3
Mou, P1
Ma, X1
Wei, R1
Ahmedy, OA1
El-Tanbouly, DM1
Al-Mokaddem, AK1
El-Said, YAM1
Wang, Y1
Liao, J1
Luo, Y1
Li, M1
Su, X1
Yu, B1
Teng, J1
Wang, H1
Lv, X1
Tan, E1
Gao, Z1
Han, B1
Shi, H1
Wang, L3
Zhu, G1
Hou, Y1
Che, Y1
Shen, DF1
Wang, ZP1
Jin, YG1
Wu, QQ1
Wang, SS1
Yuan, Y1
Ciszewski, L1
Lu-Nguyen, N1
Slater, A1
Brennan, A1
Williams, HEL1
Dickson, G1
Searle, MS1
Popplewell, L1
Jiang, X1
Cheng, C1
Chen, J1
Huang, S1
Xu, M1
Liu, S1
Bansod, S1
Doijad, N1
Godugu, C1
Bai, F1
Tao, H1
Wang, P1
Zhou, X1
Wang, F1
Liu, C1
Huang, Y1
Xiao, Y1
Deng, J1
Li, C1
Gong, X1
Gui, Z1
Huang, J2
Zhang, Y1
Liu, Y1
Ye, X2
Li, X1
Rajabi, S1
Najafipour, H1
Jafarinejad-Farsangi, S1
Joukar, S1
Beik, A1
Askaripour, M1
Jafari, E1
Safi, Z1
Xiong, W1
Xiong, SH1
Chen, QL1
Linghu, KG1
Zhao, GD1
Chu, JMT1
Wong, GTC1
Li, J3
Hu, YJ1
Wang, YT1
Yu, H1
Li, Z1
Zhang, W1
Hua, Y1
Song, Y1
Li, G1
Xing, W1
Zhang, M2
Geng, F1
Yang, H1
Zhang, H1
Zhang, X3
Dong, L1
Gao, F1
Wan, X1
Liu, L1
Zhao, Y1
Huang, WJ1
Zhang, Q1
Miao, GG1
Chen, W1
Xie, HG2
Cao, CC1
Li, MH1
Zhang, YJ1
Yu, YH1
Yang, SH1
Iqbal, J1
Mi, QY1
Li, B1
Wang, ZM1
Mao, WX1
Chen, SL1
Wang, FM1
Yang, YJ1
Ma, LL1
Tian, XJ1
He, YQ1
Ni, WJ1
Ding, HH1
Zhou, H1
Qiu, YY1
Tang, LQ1
Pietra, D1
Borghini, A1
Bianucci, AM1
Chang, W1
Meng, Z1
Yu, Y1
Yao, F1
Hatch, GM1
Daskalopoulos, EP1
Dufeys, C1
Bertrand, L1
Beauloye, C1
Horman, S1
Liu, X1
Ye, L1
Yuan, H1
Yang, Z1
Xiong, F1
Chen, C1
Liu, P2
Huang, H2
Lu, K1
Shen, Y1
He, J1
Liu, G1
Song, W1
Liu, W1
Shen, X1
Lan, T1
Li, W1
Jiang, Q1
Xie, X1

Reviews

1 review available for berberine and Fibrosis

ArticleYear
AMPK in cardiac fibrosis and repair: Actions beyond metabolic regulation.
    Journal of molecular and cellular cardiology, 2016, Volume: 91

    Topics: Aging; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Berberine; Cardiomegaly; Extracell

2016

Other Studies

27 other studies available for berberine and Fibrosis

ArticleYear
Evaluation of the effects of berberine in the prevention of epidural fibrosis in rats: An experimental research.
    Saudi medical journal, 2022, Volume: 43, Issue:4

    Topics: Animals; Berberine; Epidural Space; Fibrosis; Laminectomy; Rats; Rats, Wistar

2022
Berberine protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition involving the inactivation of the NLRP3 inflammasome.
    Renal failure, 2022, Volume: 44, Issue:1

    Topics: Animals; Berberine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibrosis; Glucose; Infl

2022
Potential Therapeutic Activity of Berberine in Thyroid-Associated Ophthalmopathy: Inhibitory Effects on Tissue Remodeling in Orbital Fibroblasts.
    Investigative ophthalmology & visual science, 2022, 09-01, Volume: 63, Issue:10

    Topics: Berberine; Fibroblasts; Fibrosis; Graves Ophthalmopathy; Humans; Hyaluronic Acid; Inflammation; Orbi

2022
Insights into the role of P2X7R/DUSP6/ERK1/2 and SIRT2/MDM2 signaling in the nephroprotective effect of berberine against cisplatin-induced renal fibrosis in rats.
    Life sciences, 2022, Nov-15, Volume: 309

    Topics: Actins; Animals; Berberine; Cisplatin; Dual Specificity Phosphatase 6; Fibrosis; Galectin 3; Kidney

2022
Berberine Alleviates Doxorubicin-Induced Myocardial Injury and Fibrosis by Eliminating Oxidative Stress and Mitochondrial Damage via Promoting Nrf-2 Pathway Activation.
    International journal of molecular sciences, 2023, Feb-07, Volume: 24, Issue:4

    Topics: Animals; Apoptosis; Berberine; Cardiotoxicity; Doxorubicin; Fibrosis; Heart Injuries; Myocytes, Card

2023
Berberine ameliorates renal interstitial inflammation and fibrosis in mice with unilateral ureteral obstruction.
    Basic & clinical pharmacology & toxicology, 2023, Volume: 133, Issue:6

    Topics: AMP-Activated Protein Kinases; Animals; Berberine; Fatty Acids; Fibrosis; Inflammasomes; Inflammatio

2023
Protective role of berberine in isoprenaline-induced cardiac fibrosis in rats.
    BMC cardiovascular disorders, 2019, 10-15, Volume: 19, Issue:1

    Topics: Animals; Berberine; Cardiomyopathies; Cell Transdifferentiation; Cells, Cultured; Coculture Techniqu

2019
G-quadruplex ligands mediate downregulation of DUX4 expression.
    Nucleic acids research, 2020, 05-07, Volume: 48, Issue:8

    Topics: Animals; Berberine; Cell Fusion; Cell Line, Tumor; Clone Cells; Down-Regulation; Enhancer Elements,

2020
Berberine Attenuates Cardiac Hypertrophy Through Inhibition of mTOR Signaling Pathway.
    Cardiovascular drugs and therapy, 2020, Volume: 34, Issue:4

    Topics: Animals; Atrial Natriuretic Factor; Berberine; Cell Line; Disease Models, Animal; Fibrosis; Hypertro

2020
Berberine attenuates severity of chronic pancreatitis and fibrosis via AMPK-mediated inhibition of TGF-β1/Smad signaling and M2 polarization.
    Toxicology and applied pharmacology, 2020, 09-15, Volume: 403

    Topics: Actins; AMP-Activated Protein Kinase Kinases; Animals; Berberine; Ceruletide; Collagen Type I; Extra

2020
Berberine hydrochloride inhibits inflammation and fibrosis after canalicular laceration repair in rabbits.
    Life sciences, 2020, Nov-15, Volume: 261

    Topics: Animals; Anti-Inflammatory Agents; Berberine; Collagen; Cytokines; Fibrosis; Inflammation; Laceratio

2020
Epiberberine ameliorated diabetic nephropathy by inactivating the angiotensinogen (Agt) to repress TGFβ/Smad2 pathway.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2021, Volume: 83

    Topics: Angiotensinogen; Animals; Berberine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibros

2021
Quercetin, Perillyl Alcohol, and Berberine Ameliorate Right Ventricular Disorders in Experimental Pulmonary Arterial Hypertension: Effects on miR-204, miR-27a, Fibrotic, Apoptotic, and Inflammatory Factors.
    Journal of cardiovascular pharmacology, 2021, 06-01, Volume: 77, Issue:6

    Topics: Animals; Antioxidants; Apoptosis; Berberine; Disease Models, Animal; Fibrosis; Hypertrophy, Right Ve

2021
Brij-functionalized chitosan nanocarrier system enhances the intestinal permeability of P-glycoprotein substrate-like drugs.
    Carbohydrate polymers, 2021, Aug-15, Volume: 266

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Berberine; Chitosan; Diabetic Neph

2021
Protective effect of berberine on renal fibrosis caused by diabetic nephropathy.
    Molecular medicine reports, 2017, Volume: 16, Issue:2

    Topics: Actins; Animals; Berberine; Blood Urea Nitrogen; Creatinine; Diabetes Mellitus, Experimental; Diabet

2017
Berberine alleviates adipose tissue fibrosis by inducing AMP-activated kinase signaling in high-fat diet-induced obese mice.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 105

    Topics: Adipose Tissue; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Berberine; Diet, H

2018
Antifibrotic cardioprotection of berberine via downregulating myocardial IGF-1 receptor-regulated MMP-2/MMP-9 expression in diabetic rats.
    American journal of physiology. Heart and circulatory physiology, 2018, 10-01, Volume: 315, Issue:4

    Topics: Actins; Animals; Berberine; Blood Glucose; Cell Differentiation; Cell Proliferation; Cells, Cultured

2018
Berberine ameliorates chronic kidney injury caused by atherosclerotic renovascular disease through the suppression of NFκB signaling pathway in rats.
    PloS one, 2013, Volume: 8, Issue:3

    Topics: Animals; Antioxidants; Atherosclerosis; Berberine; Biomarkers; Fibrosis; Inflammation; Male; NF-kapp

2013
Berberine improves pressure overload-induced cardiac hypertrophy and dysfunction through enhanced autophagy.
    European journal of pharmacology, 2014, Apr-05, Volume: 728

    Topics: Animals; Arterial Pressure; Autophagy; Berberine; Blotting, Western; Body Weight; Cardiomegaly; Card

2014
Berberine ameliorates renal interstitial fibrosis induced by unilateral ureteral obstruction in rats.
    Nephrology (Carlton, Vic.), 2014, Volume: 19, Issue:9

    Topics: Actins; Animals; Berberine; Biomarkers; Catalase; Cytoprotection; Disease Models, Animal; Fibrosis;

2014
Renoprotective effects of berberine through regulation of the MMPs/TIMPs system in streptozocin-induced diabetic nephropathy in rats.
    European journal of pharmacology, 2015, Oct-05, Volume: 764

    Topics: Animals; Berberine; Blood Glucose; Blotting, Western; Collagen Type IV; Cytoprotection; Diabetes Mel

2015
In vitro studies of antifibrotic and cytoprotective effects elicited by proto-berberine alkaloids in human dermal fibroblasts.
    Pharmacological reports : PR, 2015, Volume: 67, Issue:6

    Topics: Berberine; Berberine Alkaloids; Cell Proliferation; Cells, Cultured; Collagen; Cytoprotection; Fibro

2015
Berberine treatment prevents cardiac dysfunction and remodeling through activation of 5'-adenosine monophosphate-activated protein kinase in type 2 diabetic rats and in palmitate-induced hypertrophic H9c2 cells.
    European journal of pharmacology, 2015, Dec-15, Volume: 769

    Topics: AMP-Activated Protein Kinases; Animals; Berberine; Cardiomegaly; Cell Line; Diabetes Mellitus, Type

2015
Protective mechanisms of berberine against experimental autoimmune myocarditis in a rat model.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2016, Volume: 79

    Topics: Animals; Autoantibodies; Autoimmune Diseases; Berberine; Body Weight; Cytokines; Disease Models, Ani

2016
Berberine attenuates high glucose-induced fibrosis by activating the G protein-coupled bile acid receptor TGR5 and repressing the S1P2/MAPK signaling pathway in glomerular mesangial cells.
    Experimental cell research, 2016, 08-15, Volume: 346, Issue:2

    Topics: Animals; Berberine; Cells, Cultured; Down-Regulation; Fibronectins; Fibrosis; Gene Knockdown Techniq

2016
[Berberine inhibits cardiac fibrosis of diabetic rats].
    Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology, 2016, Volume: 32, Issue:10

    Topics: Animals; Berberine; Collagen Type III; Connective Tissue Growth Factor; Diabetes Mellitus, Experimen

2016
Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury.
    European journal of pharmacology, 2010, Jul-25, Volume: 638, Issue:1-3

    Topics: Animals; Berberine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Down-Regulation; Extrac

2010